Last update 06 Dec 2024

[18F]FP-R01-MG

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms
[18F]FP-R01-MG-F2
Target
αvβ6
Mechanism
αvβ6 antagonists(Integrin alpha-V/beta-6 antagonists)
Therapeutic Areas
Respiratory DiseasesOther DiseasesInfectious Diseases+ [3]
Active Indication
Idiopathic Pulmonary FibrosisCholangitis, SclerosingCOVID-19+ [1]
Inactive Indication-
Originator Organization
Beijing Xiehe Bioengineering United Company
Active Organization
Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.Stanford UniversityStanford UniversityBeijing Xiehe Bioengineering United Company
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with [18F]FP-R01-MG
NCT03183570 / RecruitingEarly Phase 1IIT
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT
NCT02683824 / CompletedEarly Phase 1IIT
Detection of Integrin Alpha-v-Beta 6 in Pancreatic Cancer With [18F]-R01-MG-F2: a First in Human Study
100 Clinical Results associated with [18F]FP-R01-MG
Login to view more data
100 Translational Medicine associated with [18F]FP-R01-MG
Login to view more data
100 Patents (Medical) associated with [18F]FP-R01-MG
Login to view more data
100 Deals associated with [18F]FP-R01-MG
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cholangitis, SclerosingPhase 1
US
Stanford UniversityStanford University
08 Nov 2017
Cholangitis, SclerosingPhase 1
US
Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.
08 Nov 2017
COVID-19Phase 1
US
Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.
08 Nov 2017
COVID-19Phase 1
US
Stanford UniversityStanford University
08 Nov 2017
Idiopathic Pulmonary FibrosisPhase 1
US
Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.
08 Nov 2017
Idiopathic Pulmonary FibrosisPhase 1
US
Stanford UniversityStanford University
08 Nov 2017
Pancreatic CancerPhase 1
US
Stanford UniversityStanford University
12 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free